Topic: British American Tobacco

Anecdotal reports and early 2020 discussions by British American Tobacco suggest that nicotine may have a prophylactic effect against COVID-19. Some vapers claim to have avoided infection despite close contact with positive cases. While scientific consensus is lacking, the "nicotine hypothesis" remains a topic of interest among those looking for alternative preventative measures.

British drug regulators have authorized an electronic cigarette device from British American Tobacco to be sold as a smoking cessation medicine. This allows the device to be prescribed by the National Health Service (NHS). Public Health England estimates that vaping is 95% safer than traditional tobacco, marking a significant shift in how e-cigarettes are regulated in the UK.